Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.42 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.40 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.34 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3012913 | 0.86 | ALDH1A1 (0.46) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL5429778 | 0.85 | CYP2A6 (0.50) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL3266649 | 0.85 | ALDH1A1 (0.44) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL505983 | 0.80 | HSD17B10 (0.52) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL15452989 | 0.80 | ALDH1A1 (0.47) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL8772467 | 0.79 | HSD17B10 (0.73) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL9860834 | 0.79 | GFER (0.42) | CYP2A6ALDH1A1KDM4EKMT2A | |
| SCHEMBL10490665 | 0.78 | ALDH1A1 (0.46) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL14330452 | 0.78 | CYP2A6 (0.44) | HSD17B10CYP2A6ALDH5A1ABATALDH1A1 | |
| SCHEMBL2842637 | 0.78 | ALDH1A1 (0.34) | ALDH1A1LMNAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114853608-A | Synthetic method of [60] fullerene hydrogen derivative catalyzed by N-heterocyclic carbene | 河南师范大学 | 2022-08-05 | — | — | CN | claimed |
| CN-115819195-A | Preparation method of pterostilbene | 三原润禾生物科技有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-109232175-A | A kind of preparation method of chloroethyl substituted aromatic compound | 四川理工学院 | 2019-01-18 | — | — | CN | disclosed |
| WO-2014130550-A1 | SUBSTITUTED DIARYL DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-28 | — | — | WO | disclosed |
| WO-2014130565-A1 | SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-28 | — | — | WO | disclosed |
| WO-2014130550-A1 | SUBSTITUTED DIARYL DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-28 | — | — | WO | disclosed |
| WO-2014130565-A1 | SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-28 | — | — | WO | disclosed |
| US-20140235613-A1 | SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| US-20140235613-A1 | SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| US-20140235585-A1 | SUBSTITUTED DIARYL DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| CN-102093270-A | Stilbene two-photon fluorescence probe for detecting intracellular silver ions | UNIV SHAOGUAN | 2011-06-15 | — | — | CN | disclosed |
| US-20090170911-A1 | NOVEL AZOLE COMPOUND | AJINOMOTO CO. INC (JP) | 2009-07-02 | — | — | US | disclosed |
| US-7517996-B2 | Azole compound | AJINOMOTO CO., INC. (JP) | 2009-04-14 | — | — | US | disclosed |
| WO-2007012670-A2 | COMPOUNDS DERIVED FROM 5-BENZYLIDENE IMIDAZOLIDINE 2,4-DIONE AND THEIR USE AS MCHR-1 ANTAGONISTS | CEREP (FR) | 2007-02-01 | — | — | WO | disclosed |
| US-20060194850-A1 | Novel azole compound | AJINOMOTO CO. INC (JP) | 2006-08-31 | — | — | US | disclosed |
| EP-0912586-B1 | FUNCTIONALIZED FERROCENYLDIPHOSPHINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-16 | — | — | EP | disclosed |
| US-6169192-B1 | LIGANDS FOR TRANSITION METAL COMPLEXES SUITABLE FOR ENANTIOSELECTIVE HYDROGENATION OF ORGANIC DOUBLE OR TRIPLE BONDS | NOVARTIS AG (CH) | 2001-01-02 | — | — | US | disclosed |
| EP-0912586-A1 | FUNCTIONALIZED FERROCENYLDIPHOSPHINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE | Novartis AG (CH) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998001457-A1 | FUNCTIONALIZED FERROCENYLDIPHOSPHINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE | NOVARTIS AG (CH) | 1998-01-15 | — | — | WO | disclosed |
| EP-0231922-A2 | Electron beam and X-ray resists | AMERICAN CYANAMID COMPANY (US) | 1987-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170911-A1 | NOVEL AZOLE COMPOUND | LPAR1, LPAR2, LPAR3 | HSD17B10 974/4885CYP2A6 1144/4885ALDH5A1 2099/4885 |
| US-20140235585-A1 | SUBSTITUTED DIARYL DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | S1PR1, S1PR2, S1PR3 | HSD17B10 3055/4885CYP2A6 1738/4885ALDH5A1 3655/4885 |
| US-20140235613-A1 | SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS | S1PR2, S1PR1, S1PR5 | HSD17B10 4334/4885CYP2A6 1817/4885ALDH5A1 3696/4885 |
| US-20060194850-A1 | Novel azole compound | LPAR1, LPAR2, LPAR3 | HSD17B10 974/4885CYP2A6 1144/4885ALDH5A1 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.